The Rasmussen Reports daily Presidential Tracking Poll for Tuesday shows that 48% of Likely U.S. Voters approve of President Trump’s job performance. Fifty (50%) disapprove. The latest figures include ...

The Rasmussen Reports daily Presidential Tracking Poll for Thursday shows that 50% of Likely U.S. Voters approve of President Trump’s job performance. Forty-eight (48%) disapprove. The latest figures ...

International outcomes in breast, cervical, and ovarian cancers highlight opportunities to improve health-care delivery for ...

The recommendations aim to reduce unnecessary ‘cumbersome’ testing and improve antibiotic stewardship in sore throat ...

Exelixis’ oral tyrosine kinase inhibitor (TKI) was tied to a 20% reduced risk of death from colorectal cancer, appearing to ...

Inhaled corticosteroids pose long-term risks in COPD management, prompting careful screening and potential de-escalation ...

The Committee on Chemists with Disabilities is planning to showcase 50 braille periodic tables in 50 states by their 50th ...

Belzutifan, pembrolizumab, and lenvatinib combination showed superior efficacy in advanced ccRCC, with high overall response rates and prolonged progression-free survival. The study supports ...

Brensocatib effectively reduces NSP activity in bronchiectasis patients, with greater reductions observed in the 25-mg dose group compared to the 10-mg group.

The probability calculated in only one tail of a distribution is half the probability of a two-tailed distribution if similar measurements were tested using both hypothesis testing tools. In a ...

The FDA has approved Epioxa™ HD 0.239% and Epioxa™ 0.177% for use in epithelium-on corneal collagen CXL for the treatment of ...